These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9187917)

  • 1. Human immunodeficiency virus and the complement system.
    Gras G; Legendre C; Richard Y; Dormont D
    Exp Clin Immunogenet; 1997; 14(1):11-5. PubMed ID: 9187917
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV and complement: hijacking an immune defense.
    Datta PK; Rappaport J
    Biomed Pharmacother; 2006 Nov; 60(9):561-8. PubMed ID: 16978830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-HIV interactions during all steps of viral pathogenesis.
    Stoiber H; Banki Z; Wilflingseder D; Dierich MP
    Vaccine; 2008 Jun; 26(24):3046-54. PubMed ID: 18191309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and human complement: inefficient virolysis and effective adherence.
    Bánki Z; Stoiber H; Dierich MP
    Immunol Lett; 2005 Mar; 97(2):209-14. PubMed ID: 15752560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement in HIV infection.
    Stoiber H; Clivio A; Dierich MP
    Annu Rev Immunol; 1997; 15():649-74. PubMed ID: 9143703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition of complement proteins and specific antibodies for binding to HIV-1 envelope antigens.
    Füst G; Prohászka Z; Hidvégi T; Thielens N; Arlaud G; Tóth FD; Kiss J; Dierich MP; Ujhelyi E
    Acta Microbiol Immunol Hung; 1994; 41 Suppl():27-31. PubMed ID: 8075944
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism.
    Sullivan BL; Takefman DM; Spear GT
    Virology; 1998 Sep; 248(2):173-81. PubMed ID: 9721226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV. Escape artist par excellence.
    Cohen J
    Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV/AIDS research. Potent HIV antibodies spark vaccine hopes.
    Cohen J
    Science; 2009 Sep; 325(5945):1195. PubMed ID: 19729632
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV pathogenesis: gp120-antibody complexes bind CD4 and kill T4 cells--immunotoxin therapy should prevent the progression of HIV to AIDS.
    Chaplin JW
    Med Hypotheses; 1999 Feb; 52(2):133-46. PubMed ID: 10340294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of microbial infections on the progression of HIV disease.
    Blanchard A; Montagnier L; Gougeon ML
    Trends Microbiol; 1997 Aug; 5(8):326-31. PubMed ID: 9263412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.
    Montefiori DC
    Springer Semin Immunopathol; 1997; 18(3):371-90. PubMed ID: 9089955
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement-opsonized HIV: the free rider on its way to infection.
    Stoiber H; Pruenster M; Ammann CG; Dierich MP
    Mol Immunol; 2005 Feb; 42(2):153-60. PubMed ID: 15488605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
    Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
    Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notes on the pathogenesis of human immunodeficiency virus infection.
    Piconi S; Clerici M
    Ann Ist Super Sanita; 1997; 33(2):219-23. PubMed ID: 9470244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibody production (IVAP) in the follow-up of pediatric human immunodeficiency virus type 1-infected patients.
    Rusconi S; Riva A; Cocchi F; Massironi E; Tornaghi R; de Maddalena C; de Pasquale MP; Galli M
    Pediatr AIDS HIV Infect; 1997 Apr; 8(2):127-9. PubMed ID: 11361779
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired phagocyte oxidative capacity in human immunodeficiency virus-infected children.
    Hayani KC; Verral SC; Pitrak DL
    J Infect Dis; 1999 Mar; 179(3):584-9. PubMed ID: 9952364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reconstitution inflammatory syndrome of the small bowel in a human immunodeficiency virus-negative patient.
    Daum S; Loddenkemper C; Schneider T
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):e27-8. PubMed ID: 17628330
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis.
    Takefman DM; Sullivan BL; Sha BE; Spear GT
    Virology; 1998 Jul; 246(2):370-8. PubMed ID: 9657955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.